Noevir Holdings Co., Ltd.TSE: 4928

Noevir Announces Consolidated Results for the First Nine Months of the Fiscal Year Ending September 30, 2024

· Issued by Noevir Holdings Co., Ltd.

Note: This document has been translated from the Japanese original for reference purpose only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

August 6, 2024

Noevir Holdings Announces Consolidated Results for the First Nine Months of

the Fiscal Year Ending September 30, 2024

(based on Japan GAAP)

Trade name:

Noevir Holdings Co., Ltd.

Listing:

Tokyo Stock Exchange, Prime Market (Securities Code: 4928)

URL:

https://www.noevirholdings.co.jp/

Representative:

Takashi Okura, President and CEO

Contact:

Junya Baba, General Manager, Accounting

Tel. +81-78-303-5121

Date of commencement of dividend payments: -

Supplemental materials for the financial results prepared: None

Results briefing for the reporting period held: None

(Amounts under one million yen have been rounded down)

1. Operating results for the first nine months of the fiscal year ending September 30, 2024 (October 1, 2023 to June 30, 2024)

(1) Consolidated operating results

(Millions of yen; percentage figures denote year-on-year change)

Net sales

Operating

Ordinary

Net income attributable

income

income

to owners of the parent

Nine months ended June 30, 2024

48,238

2.9 %

9,015

2.7 %

9,169

2.3 %

4,490

(4.4) %

Nine months ended June 30, 2023

46,882

2.2 %

8,781

10.3 %

8,959

10.2 %

4,695

0.9 %

Note: Comprehensive income:

Nine months ended June 30, 2024: 5,309 million yen [(2.6)%]

Nine months ended June 30, 2023: 5,450 million yen [11.9%]

EPS (Yen)

Diluted EPS (Yen)

Nine months ended June 30, 2024

131.48

-

Nine months ended June 30, 2023

137.48

-

(2) Consolidated financial position

(Millions of yen)

Total assets

Net assets

Equity ratio (%)

As of June 30, 2024

75,443

50,999

66.8

As of September 30, 2023

77,246

53,205

68.3

[Reference] Equity:

As of June 30, 2024: 50,421 million yen

As of September 30, 2023: 52,790 million yen

- 1 -

2. Cash dividends

(Yen)

Annual dividends

1st quarter

2nd quarter

3rd quarter

Year-end

Total

Fiscal year ended September 30, 2023

-

0.00

-

220.00

220.00

Fiscal year ended September 30, 2024

-

0.00

-

Fiscal year ending September 30, 2024

220.00

220.00

(forecast)

Note: Revisions from the most recently announced dividend forecast: None

3. Consolidated earnings forecasts for the fiscal year ending September 30, 2024 (October 1, 2023 to September 30, 2024)

(Millions of yen; percentage figures denote year-on-year change)

Net income

Net sales

Operating income

Ordinary income

attributable to

EPS (Yen)

owners of the parent

Full year

63,000

0.7%

11,200

1.6%

11,400

0.9%

7,800

1.6%

228.36

Note: Revisions from the most recently announced consolidated earnings forecast: None

* Notes

  1. Significant changes in the scope of consolidation during the period: None
  2. Special accounting treatment for preparation of quarterly consolidated financial statements: None
  3. Changes in accounting principles, procedures, disclosure methods, etc.
    1. Changes associated with revision in accounting standards: None
    2. Other changes: None
    3. Changes in accounting estimates: None
    4. Restatements: None
  4. Shares outstanding (common stock)
    1. Shares outstanding (including treasury stock)

As of June 30, 2024:

34,156,623

As of September 30, 2023:

34,156,623

2)

Treasury shares outstanding

As of June 30, 2024:

318

As of September 30, 2023:

270

3)

Average shares outstanding over quarter

Nine months ended June 30, 2024: 34,156,345

Nine months ended June 30, 2023: 34,156,353

  • Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: None
  • Explanation regarding the appropriate use of business performance forecasts
    Forward-looking statements included in these materials, such as forecasts of business performance, are based on information known to the Company's management as of the time of writing, and reflect judgments believed to be reasonable on the basis of that information. There is, therefore, a possibility that actual business performance figures will differ substantially from our forecasts as a result of changes in the economic situation and other unforeseeable factors. Please refer to "(3) Estimates and forecasts pertaining to future plans and business results" under "1. Qualitative information regarding quarterly consolidated business performance" on page 5 of the Attached Material.
    • 2 -

Contents of the Attached Material

1. Operating results and financial information

4

(1)

Operating results for the first nine months of the fiscal year ending September 30, 2024

4

(2)

Financial position as of June 30, 2024

4

(3)

Estimates and forecasts pertaining to future plans and business results

5

2. Quarterly consolidated financial statements and notes

6

(1)

Quarterly consolidated balance sheets

6

(2)

Quarterly consolidated statements of income and comprehensive income

8

(3)

Quarterly consolidated statements of cash flows

10

(4)

Notes to the quarterly consolidated financial statements

11

(Note on assumptions for going concern)

11

(Note on significant changes in the amount of shareholders' equity)

11

(Note on segment information)

12

- 3 -

1. Operating results and financial information

  1. Operating results for the first nine months of the fiscal year ending September 30, 2024 Consolidated operating results for the first nine months of the fiscal year ending September 30, 2024 (October 1, 2023 to June 30, 2024)

Nine months ended

Nine months ended

June 30, 2023

June 30, 2024

Change

Change

Net sales

% of Total

Net sales

% of Total

(Millions of yen)

(%)

(Millions of yen)

(Millions of yen)

Net sales

46,882

100.0

48,238

100.0

1,356

2.9

Cosmetics

36,600

78.1

38,099

79.0

1,498

4.1

Pharmaceuticals

8,646

18.4

8,265

17.1

(381)

(4.4)

& Health Food

Other

1,634

3.5

1,873

3.9

238

14.6

Nine months ended

Nine months ended

June 30, 2023

June 30, 2024

Change

Change

Amount

% of Net sales

Amount

% of Net sales

(Millions of yen)

(%)

(Millions of yen)

(Millions of yen)

Operating income

8,781

18.7

9,015

18.7

234

2.7

Ordinary income

8,959

19.1

9,169

19.0

210

2.3

Net income

4,695

10.0

4,490

9.3

(204)

(4.4)

attributable to

owners of the parent

During the first nine months of fiscal 2024 (October 1, 2023 to June 30, 2024), economic trends remained uncertain, although some signs of gradual recovery were observed.

In this environment, the Company is working to realize the concept of its medium-term management plan: "Realizing steady corporate growth by securing sustainability in every Group business segment."

As a result, net sales for the first nine months of fiscal 2024 came to 48,238 million yen (up 2.9% year on year), operating income was 9,015 million yen (up 2.7%), ordinary income was 9,169 million yen (up 2.3%),

and net income attributable to owners of the parent came to 4,490 million yen (down 4.4%).

In the Cosmetics segment, net sales totaled 38,099 million yen (up 4.1% year on year), and segment income came to 9,606 million yen (up 3.0%).

In the Pharmaceuticals & Health Food segment, net sales totaled 8,265 million yen (down 4.4% year on year), and segment income came to 954 million yen (down 4.9%).

In the Other segment, net sales totaled 1,873 million yen (up 14.6% year on year), and segment income came to 222 million yen (up 32.8%).

(2) Financial position as of June 30, 2024

Total assets as of June 30, 2024 stood at 75,443 million yen, a decrease of 1,803 million yen from the previous fiscal year-end. This was mainly due to a decrease in other receivables of 1,578 million yen.

Total liabilities came to 24,443 million yen, an increase of 402 million yen from the previous fiscal year-end. This mainly reflected an increase in notes and accounts payable of 520 million yen.

Net assets came to 50,999 million yen, a decrease of 2,205 million yen from the previous fiscal year-end. This was primarily attributable to a decrease in retained earnings of 3,023 million yen, due to the payment of 7,514 million yen in dividends at the previous fiscal year-end, which was partly offset by net income attributable to owners of the parent of 4,490 million yen.

As a result, the equity ratio stood at 66.8%.

- 4 -

(Consolidated cash flows)

Cash and cash equivalents (hereinafter, "cash") on a consolidated basis as of the end of the period under review stood at 28,091 million yen, an increase of 1,925 million yen compared with the previous fiscal year-end.

The status of each cash flow together with the factors contributing to their increase or decrease for the first nine months of fiscal 2024 are presented as follows.

(Cash flows from operating activities)

Net cash provided by operating activities amounted to 7,533 million yen (1,578 million yen more than in the corresponding period of the previous fiscal year). The main item increasing cash was 9,185 million yen in income before income taxes.

(Cash flows from investing activities)

Net cash provided by investing activities came to 1,781 million yen (an increase of 2,625 million yen from the net cash used in the corresponding period of the previous fiscal year). The principal cash inflow was 2,697 million yen in proceeds from withdrawal of time deposits, whereas the principal cash outflows were 409 million yen for purchase of property, plant and equipment and 336 million yen for purchase of intangible assets.

(Cash flows from financing activities)

Net cash used in financing activities came to 7,585 million yen (173 million yen more than in the corresponding period of the previous fiscal year). This was mainly due to the payment of 7,520 million yen in dividends.

(3) Estimates and forecasts pertaining to future plans and business results

The consolidated business performance forecasts for the full year ending September 30, 2024, announced on November 7, 2023, remain unchanged.

- 5 -

2. Quarterly consolidated financial statements and notes

  1. Quarterly consolidated balance sheets

(Millions of yen)

Previous fiscal year

As of

(As of September 30,

June 30, 2024

2023)

ASSETS

Current assets

Cash and cash equivalents

28,883

28,309

Notes and accounts receivable

10,495

10,323

Merchandise and finished goods

6,352

6,706

Work in progress

141

113

Raw materials and purchased supplies

1,653

1,567

Other receivables

3,057

1,479

Other

597

676

Allowance for doubtful accounts

(6)

(6)

Total current assets

51,175

49,169

Non-current assets

Property, plant and equipment

Buildings and structures, net

4,887

4,650

Equipment and vehicles, net

650

712

Land

13,554

13,559

Lease assets, net

846

786

Construction in progress

71

3

Other, net

183

173

Total property, plant and equipment

20,193

19,885

Intangible assets

Goodwill

178

167

Software

89

74

Other

431

745

Total intangible assets

699

986

Investments and other assets

Investment securities

2,611

3,244

Deferred tax assets

1,455

1,090

Other

1,132

1,084

Allowance for doubtful accounts

(20)

(18)

Total investments and other assets

5,178

5,402

Total non-current assets

26,071

26,273

Total assets

77,246

75,443

- 6 -

(Millions of yen)

Previous fiscal year

As of

(As of September 30,

June 30, 2024

2023)

LIABILITIES

Current liabilities

Notes and accounts payable

2,903

3,423

Lease obligations

87

86

Other accounts payable

3,012

2,539

Income tax payable

2,146

2,671

Reserve for bonuses

97

55

Other

2,258

2,286

Total current liabilities

10,506

11,064

Long-term liabilities

Lease obligations

827

763

Guarantee deposits received

11,583

11,251

Deferred tax liabilities

461

705

Net defined benefit liability

534

532

Other

127

125

Total long-term liabilities

13,534

13,378

Total liabilities

24,040

24,443

NET ASSETS

Shareholders' equity

Common stock

7,319

7,319

Retained earnings

43,312

40,289

Treasury stock

(1)

(1)

Total shareholders' equity

50,629

47,606

Accumulated other comprehensive income

Net unrealized gain on other securities

1,607

2,045

Foreign currency translation adjustments

558

769

Remeasurements of defined benefit plans, net of tax

(5)

(0)

Total accumulated other comprehensive income

2,160

2,814

Non-controlling interests

415

578

Total net assets

53,205

50,999

Total liabilities and net assets

77,246

75,443

- 7 -

  1. Quarterly consolidated statements of income and comprehensive income Quarterly consolidated statements of income
    First nine months of the fiscal year ending September 30, 2024

(Millions of yen)

Nine months ended

Nine months ended

June 30, 2023

June 30, 2024

Net sales

46,882

48,238

Cost of sales

14,503

15,409

Gross profit

32,378

32,829

Selling, general and administrative expenses

23,597

23,813

Operating income

8,781

9,015

Non-operating income

Interest income

21

32

Dividend income

21

23

Gain on currency translation

-

19

Other

140

78

Total

184

153

Non-operating expenses

Loss on currency translation

6

-

Other

0

0

Total

6

0

Ordinary income

8,959

9,169

Extraordinary income

Gain on sale of fixed assets

7

16

Total

7

16

Extraordinary losses

Loss on disposal of fixed assets

3

0

Total

3

0

Income before income taxes

8,963

9,185

Income taxes - basic

3,698

4,147

Income taxes - deferred

436

423

Total

4,134

4,570

Net income

4,828

4,615

Net income attributable to non-controlling interests

132

124

Net income attributable to owners of the parent

4,695

4,490

- 8 -

Quarterly consolidated statements of comprehensive income

First nine months of the fiscal year ending September 30, 2024

(Millions of yen)

Nine months ended

Nine months ended

June 30, 2023

June 30, 2024

Net income

4,828

4,615

Other comprehensive income

Net unrealized gain on other securities

604

438

Foreign currency translation adjustments

14

250

Remeasurements of defined benefit plans, net of tax

2

5

Total

622

693

Comprehensive income

5,450

5,309

(Breakdown)

Comprehensive income attributable to owners of the parent

5,322

5,145

Comprehensive income attributable to non-controlling interests

128

163

- 9 -

(3) Quarterly consolidated statements of cash flows

(Millions of yen)

Nine months ended

Nine months ended

June 30, 2023

June 30, 2024

Cash flows from operating activities

Income before income taxes

8,963

9,185

Depreciation

869

712

Amortization of goodwill

23

23

Increase (decrease) in reserve for doubtful accounts

(0)

(2)

Increase (decrease) in reserve for bonuses

(47)

(42)

Increase (decrease) in net defined benefit asset and liability

10

(2)

Increase (decrease) in accounts payable due to transition to a

(992)

(828)

retirement benefit plan

Interest and dividends received

(43)

(56)

Loss (gain) on currency translation

2

(9)

Loss (gain) on sales of disposal of non-current assets

(3)

(16)

Decrease (increase) in trade receivables

(501)

207

Decrease (increase) in inventories

(790)

(171)

Increase (decrease) in trade payables

331

497

Increase (decrease) in guarantee deposits

(334)

(331)

Other

328

384

Subtotal

7,813

9,551

Interest and dividends received

35

54

Income tax (paid) refunded

(1,894)

(2,072)

Net cash provided by (used in) operating activities

5,954

7,533

Cash flows from investing activities

Expenditure for deposit to time deposits

(196)

(197)

Proceeds from withdrawal of time deposits

196

2,697

Purchase of investment securities

(1)

(1)

Purchase of property, plant and equipment

(537)

(409)

Proceeds from sale of property, plant and equipment

10

28

Purchase of intangible assets

(315)

(336)

Net cash provided by (used in) investing activities

(844)

1,781

Cash flows from financing activities

Purchase of treasury stock

-

(0)

Cash dividends paid

(7,340)

(7,520)

Other

(71)

(64)

Net cash provided by (used in) financing activities

(7,411)

(7,585)

Effects of exchange rate changes on cash and cash equivalents

(1)

196

Net change in cash and cash equivalents

(2,303)

1,925

Cash and cash equivalents, beginning of the period

29,530

26,166

Cash and cash equivalents, end of the period

27,226

28,091

- 10 -

Company analysis